HEADER HYDROLASE/HYDROLASE INHIBITOR 01-MAR-07 2P0R
TITLE STRUCTURE OF HUMAN CALPAIN 9 IN COMPLEX WITH LEUPEPTIN
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: CALPAIN-9;
COMPND 3 CHAIN: A, B;
COMPND 4 FRAGMENT: MINICALPAIN;
COMPND 5 SYNONYM: DIGESTIVE TRACT-SPECIFIC CALPAIN; NCL-4; CG36 PROTEIN;
COMPND 6 EC: 3.4.22.52;
COMPND 7 ENGINEERED: YES;
COMPND 8 MOL_ID: 2;
COMPND 9 MOLECULE: LEUPEPTIN;
COMPND 10 CHAIN: D, E;
COMPND 11 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: CAPN9, NCL4;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)GOLD;
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28-LIC;
SOURCE 11 MOL_ID: 2;
SOURCE 12 SYNTHETIC: YES;
SOURCE 13 ORGANISM_SCIENTIFIC: ACTINOMYCETES STREPTOMYCES ROSEUS MA 839-A1;
SOURCE 14 ORGANISM_TAXID: 66430
KEYWDS INHIBITOR COMPLEX; ALPHA-BETA PROTEIN; HYDROLASE; CALCIUM-DEPENDENT
KEYWDS 2 ENZYME; STRUCTURAL GENOMICS; STRUCTURAL GENOMICS CONSORTIUM; SGC,
KEYWDS 3 HYDROLASE-HYDROLASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR T.L.DAVIS,R.PARAMANATHAN,J.R.WALKER,C.BUTLER-COLE,P.J.FINERTY JR.,
AUTHOR 2 J.WEIGELT,M.SUNDSTROM,C.H.ARROWSMITH,A.M.EDWARDS,A.BOCHKAREV,S.DHE-
AUTHOR 3 PAGANON,STRUCTURAL GENOMICS CONSORTIUM (SGC)
REVDAT 6 30-OCT-24 2P0R 1 REMARK
REVDAT 5 30-AUG-23 2P0R 1 REMARK SEQADV LINK
REVDAT 4 13-JUL-11 2P0R 1 VERSN
REVDAT 3 03-JUN-08 2P0R 1 VERSN
REVDAT 2 10-APR-07 2P0R 1 AUTHOR JRNL
REVDAT 1 20-MAR-07 2P0R 0
JRNL AUTH T.L.DAVIS,R.PARAMANATHAN,J.R.WALKER,C.BUTLER-COLE,
JRNL AUTH 2 P.J.FINERTY JR.,J.WEIGELT,M.SUNDSTROM,C.H.ARROWSMITH,
JRNL AUTH 3 A.M.EDWARDS,A.BOCHKAREV,S.DHE-PAGANON
JRNL TITL STRUCTURES OF HUMAN MINICALPAINS BOUND TO INHIBITORS
JRNL REF TO BE PUBLISHED
JRNL REFN
REMARK 2
REMARK 2 RESOLUTION. 2.50 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.2
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.43
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0
REMARK 3 NUMBER OF REFLECTIONS : 27861
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.213
REMARK 3 R VALUE (WORKING SET) : 0.210
REMARK 3 FREE R VALUE : 0.269
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100
REMARK 3 FREE R VALUE TEST SET COUNT : 1491
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.56
REMARK 3 REFLECTION IN BIN (WORKING SET) : 1980
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0
REMARK 3 BIN R VALUE (WORKING SET) : 0.3510
REMARK 3 BIN FREE R VALUE SET COUNT : 94
REMARK 3 BIN FREE R VALUE : 0.4190
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 5162
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 5
REMARK 3 SOLVENT ATOMS : 270
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 53.90
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.86
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 0.03000
REMARK 3 B22 (A**2) : 0.03000
REMARK 3 B33 (A**2) : -0.05000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.501
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.302
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.226
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.536
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.905
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5274 ; 0.012 ; 0.022
REMARK 3 BOND LENGTHS OTHERS (A): 3651 ; 0.002 ; 0.020
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7131 ; 1.385 ; 1.933
REMARK 3 BOND ANGLES OTHERS (DEGREES): 8798 ; 0.901 ; 3.000
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 636 ; 7.545 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 270 ;34.976 ;23.667
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 862 ;14.523 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 39 ;15.515 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 738 ; 0.079 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5933 ; 0.004 ; 0.020
REMARK 3 GENERAL PLANES OTHERS (A): 1174 ; 0.001 ; 0.020
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1220 ; 0.214 ; 0.200
REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3809 ; 0.193 ; 0.200
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2494 ; 0.181 ; 0.200
REMARK 3 NON-BONDED TORSION OTHERS (A): 2716 ; 0.086 ; 0.200
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 274 ; 0.197 ; 0.200
REMARK 3 H-BOND (X...Y) OTHERS (A): 3 ; 0.076 ; 0.200
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 11 ; 0.127 ; 0.200
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 10 ; 0.127 ; 0.200
REMARK 3 SYMMETRY VDW OTHERS (A): 36 ; 0.275 ; 0.200
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 4 ; 0.158 ; 0.200
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3349 ; 0.621 ; 1.500
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1306 ; 0.362 ; 1.500
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5086 ; 1.049 ; 2.000
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2325 ; 1.199 ; 3.000
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2045 ; 1.810 ; 4.500
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS
REMARK 4
REMARK 4 2P0R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-MAR-07.
REMARK 100 THE DEPOSITION ID IS D_1000041822.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 10-JAN-07
REMARK 200 TEMPERATURE (KELVIN) : 100.0
REMARK 200 PH : 5.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418
REMARK 200 MONOCHROMATOR : GRAPHITE
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33145
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500
REMARK 200 RESOLUTION RANGE LOW (A) : 30.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0
REMARK 200 DATA REDUNDANCY : 9.100
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.08300
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.5000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59
REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6
REMARK 200 DATA REDUNDANCY IN SHELL : 3.70
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : 0.64600
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 1NQA
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 54.35
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 14.7% PEG 8000, 10% GLYCEROL, 0.1M NA
REMARK 280 -CACODYLATE, 0.15M AMMONIUM SULFATE, PH 5.5, VAPOR DIFFUSION,
REMARK 280 SITTING DROP, TEMPERATURE 291K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z+1/2
REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4
REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4
REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4
REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4
REMARK 290 7555 Y,X,-Z
REMARK 290 8555 -Y,-X,-Z+1/2
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 86.68900
REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 48.58250
REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 48.58250
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 43.34450
REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 48.58250
REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 48.58250
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 130.03350
REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 48.58250
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 48.58250
REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 43.34450
REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 48.58250
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 48.58250
REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 130.03350
REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 86.68900
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 300 REMARK: ONE MOLECULE OF THE ASYMMETRIC UNIT IS THE BIOLOGICAL
REMARK 300 ASSEMBLY
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 5020 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 27610 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -73.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D, E
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 400
REMARK 400 COMPOUND
REMARK 400 THE LEUPEPTIN IS SUPPOSED TO BE COVALENTLY CONNECTED TO ACTIVE_SITE
REMARK 400 CYS 97 OF THE ENZYME TO FORM A HEMITHIOACETAL, BUT THE DISTANCES
REMARK 400 ARE BEYOND 2.3 ANGSTROMS.
REMARK 400
REMARK 400 THE LEUPEPTIN IS OLIGOPEPTIDE, A MEMBER OF ENZYME INHIBITOR CLASS.
REMARK 400
REMARK 400 GROUP: 1
REMARK 400 NAME: LEUPEPTIN
REMARK 400 CHAIN: D, E
REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER
REMARK 400 DESCRIPTION: NULL
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 8
REMARK 465 SER A 9
REMARK 465 PRO A 10
REMARK 465 GLN A 11
REMARK 465 ALA A 12
REMARK 465 HIS A 13
REMARK 465 PRO A 14
REMARK 465 VAL A 15
REMARK 465 PRO A 16
REMARK 465 LYS A 17
REMARK 465 ASP A 18
REMARK 465 PRO A 338
REMARK 465 ASP A 339
REMARK 465 ALA A 340
REMARK 465 GLY B 8
REMARK 465 SER B 9
REMARK 465 PRO B 10
REMARK 465 GLN B 11
REMARK 465 ALA B 12
REMARK 465 HIS B 13
REMARK 465 PRO B 14
REMARK 465 VAL B 15
REMARK 465 PRO B 16
REMARK 465 LYS B 17
REMARK 465 ASP B 18
REMARK 465 PRO B 338
REMARK 465 ASP B 339
REMARK 465 ALA B 340
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 OH TYR A 217 NE2 GLN A 263 1.77
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 OE1 GLU A 194 NH2 ARG B 297 4454 1.65
REMARK 500 CD ARG B 297 CD1 LEU D 356 3555 1.78
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 PHE A 159 -135.91 -97.19
REMARK 500 VAL A 283 109.99 70.89
REMARK 500 TRP A 285 137.79 -31.68
REMARK 500 ALA B 50 74.16 -68.07
REMARK 500 GLU B 59 -147.81 -124.49
REMARK 500 ASN B 76 73.15 -113.23
REMARK 500 ILE B 89 79.97 -106.02
REMARK 500 PRO B 118 150.11 -48.29
REMARK 500 ALA B 128 29.72 -147.10
REMARK 500 HIS B 138 -51.38 76.38
REMARK 500 SER B 139 -4.19 -147.77
REMARK 500 PHE B 159 -135.53 -95.86
REMARK 500 GLU B 214 16.36 -64.22
REMARK 500 ALA B 239 -30.40 76.64
REMARK 500 PHE B 266 113.34 -168.70
REMARK 500 GLN B 282 151.73 177.49
REMARK 500 VAL B 283 110.20 73.16
REMARK 500 SER B 292 41.02 -108.47
REMARK 500 ASP B 313 75.45 -68.61
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS
REMARK 500
REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH
REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED
REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND
REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES.
REMARK 500 MODEL OMEGA
REMARK 500 GLN A 137 HIS A 138 -83.27
REMARK 500 SER B 58 GLU B 59 -93.31
REMARK 500 GLU B 59 ARG B 60 -102.15
REMARK 500
REMARK 500 REMARK: NULL
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 CA A1003 CA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 LEU A 81 O
REMARK 620 2 GLY A 83 O 92.3
REMARK 620 3 ASP A 88 OD1 149.0 115.5
REMARK 620 4 ASP A 88 OD2 159.4 74.9 50.3
REMARK 620 5 GLU A 167 OE1 99.0 136.6 70.7 80.6
REMARK 620 6 GLU A 167 OE2 81.6 89.8 110.4 82.3 51.3
REMARK 620 7 HOH A1007 O 104.9 78.4 70.1 88.6 136.6 166.7
REMARK 620 8 HOH A1168 O 75.1 153.3 73.9 123.0 69.6 110.9 82.2
REMARK 620 N 1 2 3 4 5 6 7
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 CA A1002 CA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 GLU A 284 OE1
REMARK 620 2 GLU A 284 OE2 49.5
REMARK 620 3 ASP A 291 OD1 73.0 122.3
REMARK 620 4 ASP A 291 OD2 76.4 110.4 40.8
REMARK 620 5 LEU A 312 O 93.1 73.5 109.8 69.0
REMARK 620 6 ASP A 314 OD1 117.4 70.7 161.8 152.0 85.4
REMARK 620 7 GLU A 316 O 81.6 91.7 83.3 123.7 163.9 83.7
REMARK 620 8 HOH A1068 O 156.9 153.3 84.0 85.9 94.2 85.0 96.6
REMARK 620 N 1 2 3 4 5 6 7
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 CA B1004 CA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 LEU B 81 O
REMARK 620 2 GLY B 83 O 79.8
REMARK 620 3 ASP B 88 OD2 157.8 80.6
REMARK 620 4 ASP B 88 OD1 152.5 122.7 49.7
REMARK 620 5 GLU B 167 OE1 108.7 131.0 76.9 70.1
REMARK 620 6 GLU B 167 OE2 86.9 81.6 79.9 110.4 51.9
REMARK 620 N 1 2 3 4 5
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 CA B1001 CA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 GLU B 284 OE2
REMARK 620 2 GLU B 284 OE1 53.1
REMARK 620 3 ASP B 291 OD1 123.0 73.6
REMARK 620 4 ASP B 291 OD2 103.1 82.0 45.0
REMARK 620 5 LEU B 312 O 79.1 116.4 113.0 69.8
REMARK 620 6 ASP B 314 OD2 117.6 160.8 119.3 117.2 73.4
REMARK 620 7 GLU B 316 O 93.2 77.5 93.9 138.1 151.9 86.9
REMARK 620 N 1 2 3 4 5 6
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 1001
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 1002
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 1003
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 1004
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 1005
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF LEUPEPTIN
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC7
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF LEUPEPTIN
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1ZIV RELATED DB: PDB
REMARK 900 RELATED ID: 2NQA RELATED DB: PDB
REMARK 999
REMARK 999 SEQUENCE
REMARK 999 THERE IS A DISCREPANCY IN THE NORINE AND PDB NUMBERING, AS NORINE
REMARK 999 COUNTS ACE AND LEU TOGETHER AS ONE RESIDUE. SO THE DBREF WILL
REMARK 999 REPORT 4 PDB RESIDUES MATCHING NORINE 3 RESIDUE
DBREF 2P0R A 10 340 UNP O14815 CAN9_HUMAN 10 340
DBREF 2P0R B 10 340 UNP O14815 CAN9_HUMAN 10 340
DBREF 2P0R D 355 358 NOR NOR00487 NOR00487 1 3
DBREF 2P0R E 355 358 NOR NOR00487 NOR00487 1 3
SEQADV 2P0R GLY A 8 UNP O14815 EXPRESSION TAG
SEQADV 2P0R SER A 9 UNP O14815 EXPRESSION TAG
SEQADV 2P0R GLY B 8 UNP O14815 EXPRESSION TAG
SEQADV 2P0R SER B 9 UNP O14815 CLONING ARTIFACT
SEQRES 1 A 333 GLY SER PRO GLN ALA HIS PRO VAL PRO LYS ASP ALA ARG
SEQRES 2 A 333 ILE THR HIS SER SER GLY GLN SER PHE GLU GLN MET ARG
SEQRES 3 A 333 GLN GLU CYS LEU GLN ARG GLY THR LEU PHE GLU ASP ALA
SEQRES 4 A 333 ASP PHE PRO ALA SER ASN SER SER LEU PHE TYR SER GLU
SEQRES 5 A 333 ARG PRO GLN ILE PRO PHE VAL TRP LYS ARG PRO GLY GLU
SEQRES 6 A 333 ILE VAL LYS ASN PRO GLU PHE ILE LEU GLY GLY ALA THR
SEQRES 7 A 333 ARG THR ASP ILE CYS GLN GLY GLU LEU GLY ASP CYS TRP
SEQRES 8 A 333 LEU LEU ALA ALA ILE ALA SER LEU THR LEU ASN GLN LYS
SEQRES 9 A 333 ALA LEU ALA ARG VAL ILE PRO GLN ASP GLN SER PHE GLY
SEQRES 10 A 333 PRO GLY TYR ALA GLY ILE PHE HIS PHE GLN PHE TRP GLN
SEQRES 11 A 333 HIS SER GLU TRP LEU ASP VAL VAL ILE ASP ASP ARG LEU
SEQRES 12 A 333 PRO THR PHE ARG ASP ARG LEU VAL PHE LEU HIS SER ALA
SEQRES 13 A 333 ASP HIS ASN GLU PHE TRP SER ALA LEU LEU GLU LYS ALA
SEQRES 14 A 333 TYR ALA LYS LEU ASN GLY SER TYR GLU ALA LEU LYS GLY
SEQRES 15 A 333 GLY SER ALA ILE GLU ALA MET GLU ASP PHE THR GLY GLY
SEQRES 16 A 333 VAL ALA GLU THR PHE GLN THR LYS GLU ALA PRO GLU ASN
SEQRES 17 A 333 PHE TYR GLU ILE LEU GLU LYS ALA LEU LYS ARG GLY SER
SEQRES 18 A 333 LEU LEU GLY CYS PHE ILE ASP THR ARG SER ALA ALA GLU
SEQRES 19 A 333 SER GLU ALA ARG THR PRO PHE GLY LEU ILE LYS GLY HIS
SEQRES 20 A 333 ALA TYR SER VAL THR GLY ILE ASP GLN VAL SER PHE ARG
SEQRES 21 A 333 GLY GLN ARG ILE GLU LEU ILE ARG ILE ARG ASN PRO TRP
SEQRES 22 A 333 GLY GLN VAL GLU TRP ASN GLY SER TRP SER ASP SER SER
SEQRES 23 A 333 PRO GLU TRP ARG SER VAL GLY PRO ALA GLU GLN LYS ARG
SEQRES 24 A 333 LEU CYS HIS THR ALA LEU ASP ASP GLY GLU PHE TRP MET
SEQRES 25 A 333 ALA PHE LYS ASP PHE LYS ALA HIS PHE ASP LYS VAL GLU
SEQRES 26 A 333 ILE CYS ASN LEU THR PRO ASP ALA
SEQRES 1 B 333 GLY SER PRO GLN ALA HIS PRO VAL PRO LYS ASP ALA ARG
SEQRES 2 B 333 ILE THR HIS SER SER GLY GLN SER PHE GLU GLN MET ARG
SEQRES 3 B 333 GLN GLU CYS LEU GLN ARG GLY THR LEU PHE GLU ASP ALA
SEQRES 4 B 333 ASP PHE PRO ALA SER ASN SER SER LEU PHE TYR SER GLU
SEQRES 5 B 333 ARG PRO GLN ILE PRO PHE VAL TRP LYS ARG PRO GLY GLU
SEQRES 6 B 333 ILE VAL LYS ASN PRO GLU PHE ILE LEU GLY GLY ALA THR
SEQRES 7 B 333 ARG THR ASP ILE CYS GLN GLY GLU LEU GLY ASP CYS TRP
SEQRES 8 B 333 LEU LEU ALA ALA ILE ALA SER LEU THR LEU ASN GLN LYS
SEQRES 9 B 333 ALA LEU ALA ARG VAL ILE PRO GLN ASP GLN SER PHE GLY
SEQRES 10 B 333 PRO GLY TYR ALA GLY ILE PHE HIS PHE GLN PHE TRP GLN
SEQRES 11 B 333 HIS SER GLU TRP LEU ASP VAL VAL ILE ASP ASP ARG LEU
SEQRES 12 B 333 PRO THR PHE ARG ASP ARG LEU VAL PHE LEU HIS SER ALA
SEQRES 13 B 333 ASP HIS ASN GLU PHE TRP SER ALA LEU LEU GLU LYS ALA
SEQRES 14 B 333 TYR ALA LYS LEU ASN GLY SER TYR GLU ALA LEU LYS GLY
SEQRES 15 B 333 GLY SER ALA ILE GLU ALA MET GLU ASP PHE THR GLY GLY
SEQRES 16 B 333 VAL ALA GLU THR PHE GLN THR LYS GLU ALA PRO GLU ASN
SEQRES 17 B 333 PHE TYR GLU ILE LEU GLU LYS ALA LEU LYS ARG GLY SER
SEQRES 18 B 333 LEU LEU GLY CYS PHE ILE ASP THR ARG SER ALA ALA GLU
SEQRES 19 B 333 SER GLU ALA ARG THR PRO PHE GLY LEU ILE LYS GLY HIS
SEQRES 20 B 333 ALA TYR SER VAL THR GLY ILE ASP GLN VAL SER PHE ARG
SEQRES 21 B 333 GLY GLN ARG ILE GLU LEU ILE ARG ILE ARG ASN PRO TRP
SEQRES 22 B 333 GLY GLN VAL GLU TRP ASN GLY SER TRP SER ASP SER SER
SEQRES 23 B 333 PRO GLU TRP ARG SER VAL GLY PRO ALA GLU GLN LYS ARG
SEQRES 24 B 333 LEU CYS HIS THR ALA LEU ASP ASP GLY GLU PHE TRP MET
SEQRES 25 B 333 ALA PHE LYS ASP PHE LYS ALA HIS PHE ASP LYS VAL GLU
SEQRES 26 B 333 ILE CYS ASN LEU THR PRO ASP ALA
SEQRES 1 D 4 ACE LEU LEU AR7
SEQRES 1 E 4 ACE LEU LEU AR7
HET ACE D 355 3
HET AR7 D 358 11
HET ACE E 355 3
HET AR7 E 358 11
HET CA A1002 1
HET CA A1003 1
HET CA A1005 1
HET CA B1001 1
HET CA B1004 1
HETNAM ACE ACETYL GROUP
HETNAM AR7 AMINO{[(4S)-4-AMINO-5,5-
HETNAM 2 AR7 DIHYDROXYPENTYL]AMINO}METHANIMINIUM
HETNAM CA CALCIUM ION
FORMUL 3 ACE 2(C2 H4 O)
FORMUL 3 AR7 2(C6 H17 N4 O2 1+)
FORMUL 5 CA 5(CA 2+)
FORMUL 10 HOH *270(H2 O)
HELIX 1 1 SER A 28 GLY A 40 1 13
HELIX 2 2 SER A 51 PHE A 56 1 6
HELIX 3 3 ARG A 69 VAL A 74 1 6
HELIX 4 4 THR A 85 ILE A 89 5 5
HELIX 5 5 ASP A 96 THR A 107 1 12
HELIX 6 6 ASN A 109 ILE A 117 1 9
HELIX 7 7 PHE A 168 ASN A 181 1 14
HELIX 8 8 TYR A 184 LYS A 188 5 5
HELIX 9 9 SER A 191 GLY A 201 1 11
HELIX 10 10 LYS A 210 ALA A 212 5 3
HELIX 11 11 ASN A 215 ARG A 226 1 12
HELIX 12 12 SER A 238 SER A 242 5 5
HELIX 13 13 SER A 293 VAL A 299 5 7
HELIX 14 14 GLY A 300 LEU A 307 1 8
HELIX 15 15 PHE A 321 PHE A 328 1 8
HELIX 16 16 SER B 28 GLY B 40 1 13
HELIX 17 17 SER B 51 PHE B 56 1 6
HELIX 18 18 ARG B 69 VAL B 74 1 6
HELIX 19 19 THR B 85 ILE B 89 5 5
HELIX 20 20 ASP B 96 LEU B 108 1 13
HELIX 21 21 ASN B 109 ILE B 117 1 9
HELIX 22 22 PHE B 168 GLY B 182 1 15
HELIX 23 23 TYR B 184 LYS B 188 5 5
HELIX 24 24 SER B 191 GLY B 201 1 11
HELIX 25 25 LYS B 210 ALA B 212 5 3
HELIX 26 26 ASN B 215 ARG B 226 1 12
HELIX 27 27 SER B 293 ARG B 297 5 5
HELIX 28 28 GLY B 300 LYS B 305 1 6
HELIX 29 29 PHE B 321 PHE B 328 1 8
SHEET 1 A 2 VAL A 66 LYS A 68 0
SHEET 2 A 2 LEU A 150 THR A 152 -1 O LEU A 150 N LYS A 68
SHEET 1 B 2 ILE A 130 GLN A 137 0
SHEET 2 B 2 GLU A 140 ASP A 147 -1 O ILE A 146 N PHE A 131
SHEET 1 C 6 ALA A 204 GLN A 208 0
SHEET 2 C 6 LYS A 330 CYS A 334 -1 O VAL A 331 N PHE A 207
SHEET 3 C 6 LEU A 229 PHE A 233 -1 N PHE A 233 O LYS A 330
SHEET 4 C 6 TYR A 256 PHE A 266 -1 O VAL A 258 N LEU A 230
SHEET 5 C 6 GLN A 269 ARG A 277 -1 O LEU A 273 N ASP A 262
SHEET 6 C 6 GLU A 316 ALA A 320 -1 O PHE A 317 N ILE A 276
SHEET 1 D 3 VAL B 66 LYS B 68 0
SHEET 2 D 3 LEU B 150 PHE B 153 -1 O THR B 152 N VAL B 66
SHEET 3 D 3 ARG B 156 LEU B 157 -1 O ARG B 156 N PHE B 153
SHEET 1 E 2 ILE B 130 GLN B 137 0
SHEET 2 E 2 GLU B 140 ASP B 147 -1 O LEU B 142 N PHE B 135
SHEET 1 F 6 VAL B 203 GLN B 208 0
SHEET 2 F 6 LYS B 330 ASN B 335 -1 O ILE B 333 N GLU B 205
SHEET 3 F 6 LEU B 229 PHE B 233 -1 N LEU B 229 O CYS B 334
SHEET 4 F 6 TYR B 256 PHE B 266 -1 O TYR B 256 N CYS B 232
SHEET 5 F 6 GLN B 269 ARG B 277 -1 O ARG B 275 N GLY B 260
SHEET 6 F 6 GLU B 316 ALA B 320 -1 O MET B 319 N ILE B 274
LINK C ACE D 355 N LEU D 356 1555 1555 1.34
LINK C LEU D 357 N AR7 D 358 1555 1555 1.33
LINK C ACE E 355 N LEU E 356 1555 1555 1.34
LINK C LEU E 357 N AR7 E 358 1555 1555 1.33
LINK NE ARG A 60 CA CA A1005 1555 1555 3.03
LINK O LEU A 81 CA CA A1003 1555 1555 2.52
LINK O GLY A 83 CA CA A1003 1555 1555 2.44
LINK OD1 ASP A 88 CA CA A1003 1555 1555 2.75
LINK OD2 ASP A 88 CA CA A1003 1555 1555 2.43
LINK OE1 GLU A 167 CA CA A1003 1555 1555 2.62
LINK OE2 GLU A 167 CA CA A1003 1555 1555 2.42
LINK OE1 GLU A 284 CA CA A1002 1555 1555 2.63
LINK OE2 GLU A 284 CA CA A1002 1555 1555 2.59
LINK OD1 ASP A 291 CA CA A1002 1555 1555 3.33
LINK OD2 ASP A 291 CA CA A1002 1555 1555 2.39
LINK O LEU A 312 CA CA A1002 1555 1555 2.46
LINK OD1 ASP A 314 CA CA A1002 1555 1555 2.49
LINK O GLU A 316 CA CA A1002 1555 1555 2.29
LINK CA CA A1002 O HOH A1068 1555 1555 2.41
LINK CA CA A1003 O HOH A1007 1555 1555 2.50
LINK CA CA A1003 O HOH A1168 1555 1555 2.21
LINK O LEU B 81 CA CA B1004 1555 1555 2.13
LINK O GLY B 83 CA CA B1004 1555 1555 2.58
LINK OD2 ASP B 88 CA CA B1004 1555 1555 2.27
LINK OD1 ASP B 88 CA CA B1004 1555 1555 2.77
LINK OE1 GLU B 167 CA CA B1004 1555 1555 2.62
LINK OE2 GLU B 167 CA CA B1004 1555 1555 2.36
LINK OE2 GLU B 284 CA CA B1001 1555 1555 2.32
LINK OE1 GLU B 284 CA CA B1001 1555 1555 2.51
LINK OD1 ASP B 291 CA CA B1001 1555 1555 2.98
LINK OD2 ASP B 291 CA CA B1001 1555 1555 2.63
LINK O LEU B 312 CA CA B1001 1555 1555 2.40
LINK OD2 ASP B 314 CA CA B1001 1555 1555 2.90
LINK O GLU B 316 CA CA B1001 1555 1555 2.41
SITE 1 AC1 5 GLU B 284 ASP B 291 LEU B 312 ASP B 314
SITE 2 AC1 5 GLU B 316
SITE 1 AC2 6 GLU A 284 ASP A 291 LEU A 312 ASP A 314
SITE 2 AC2 6 GLU A 316 HOH A1068
SITE 1 AC3 6 LEU A 81 GLY A 83 ASP A 88 GLU A 167
SITE 2 AC3 6 HOH A1007 HOH A1168
SITE 1 AC4 4 LEU B 81 GLY B 83 ASP B 88 GLU B 167
SITE 1 AC5 1 ARG A 60
SITE 1 AC6 13 GLN A 91 GLY A 95 CYS A 97 TRP A 98
SITE 2 AC6 13 LYS A 188 GLY A 189 GLY A 190 PHE A 233
SITE 3 AC6 13 GLU A 243 GLY A 253 HOH A1149 GLN B 62
SITE 4 AC6 13 ARG B 297
SITE 1 AC7 12 GLU A 59 GLY B 95 ASP B 96 CYS B 97
SITE 2 AC7 12 TRP B 98 LYS B 188 GLY B 189 GLY B 190
SITE 3 AC7 12 PHE B 233 SER B 242 GLY B 253 HOH B1105
CRYST1 97.165 97.165 173.378 90.00 90.00 90.00 P 41 21 2 16
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.010292 0.000000 0.000000 0.00000
SCALE2 0.000000 0.010292 0.000000 0.00000
SCALE3 0.000000 0.000000 0.005768 0.00000